Kainos Laboratories, Inc. (4556) Stock Statistics & Valuation Metrics

Kainos Laboratories, Inc. has a market cap or net worth of ¥9.30B. The enterprise value is ¥6.00B.

Kainos Laboratories, Inc. has 4,558,860 shares outstanding. The number of shares has decreased by -2.65% in one year.

Kainos Laboratories, Inc.’s return on equity (ROE) is 0.06 and return on invested capital (ROIC) is 6.72%.

The current PE Ratio of Kainos Laboratories, Inc. is 21.3. Kainos Laboratories, Inc.’s PEG ratio is -0.71.

In the last 12 months, Kainos Laboratories, Inc. had revenue of 5.48B and earned 449.15M in profits. Earnings per share was 106.19.

In the last 12 months, operating cash flow was ― and capital expenditures ―, giving a free cash flow of ― billion.

Kainos Laboratories, Inc. pays an annual dividend of ¥32, resulting in a dividend yield of 2.53%

Kainos Laboratories, Inc. upcoming earnings date is Jul 27, 2026, TBA (Confirmed).

Kainos Laboratories, Inc. as a current ratio of 3.31, with Debt / Equity ratio of ―

In the past 12 months, Kainos Laboratories, Inc. has paid 185.04M in taxes.

Kainos Laboratories, Inc. EV to EBITDA ratio is 7.06, with an EV/FCF ratio of 10.93.

Kainos Laboratories, Inc. has ― in cash and marketable securities with ― in debt, giving a net cash position of ― billion.

Gross margin is ―, with operating margin of 13.64%, and net profit margin of 8.20%.

The average price target for Kainos Laboratories, Inc. is ―, which is 11.43% higher than the current price. The consensus rating is ―